Pravin U. Dugel, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Pravin U. Dugel, M.D.
Pravin U. Dugel, M.D. is recorded as CEO and Chairman at Ocular Therapeutix, Inc (OCUL). Ocular Therapeutix, Inc reported in an 8-K filed April 18, 2024 that Pravin U. Dugel, M.D. was appointed President and Chief Executive Officer, effective April 14, 2024.
“On April 14, 2024 (the "Transition Date"), the board of directors of Ocular Therapeutix, Inc. (the "Company") appointed Pravin U. Dugel, M.D., to serve as President and Chief Executive Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-04-14–present
-
Current
2024-02-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ocular Therapeutix, Inc
Other people whose current roles at this company are on record from its filings.
- Pravin Dugel CEO
- Pravin U. Dugel CEO, Chairman, Board Member
- Charles Warden Chairman, Board Member
- Jason Robins CFO
- Donald Notman COO
- Philip C. Strassburger General Counsel
- Adrienne L. Graves Board Member
- Adrienne L. Graves, Ph.D. Board Member
- Jeffrey Heier Board Member
- Jeffrey S. Heier, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.